Onkologie. 2012:6(1):28-30

Neoadjuvant therapy of pancreatic adenocarcinoma

Igor Richter¹, Josef Dvořák², Magda Macháňová¹, Jiří Bartoš¹

¹ Onkologické oddělení Krajské nemocnice Liberec, a. s.

² Klinika onkologie a radioterapie LF UK a FN Hradec Králové

Pancreatic adenocarcinoma is one of the oncological disease with the markedly poor prognosis. A searching of the new treatment options

are desirable to improve this fact. Only a radical resection of tumor is a chance of long-term survival. A possible procedure leads

to this point is neoadjuvant treatment. There was a series of clinical trial that evaluated its efficacy. Unfortunately, the results from the

third phases of the randomized multicenter clinical trials be missing today. Therefore the neoadjuvant treatment of (pankreas cancer)

pancreatic adenocarcinoma is not recommended in primary treatment of the resectable disease. In the traetment of the borderline

disease is neoadjuvant treatment possible procedure.

Keywords: pancreatic adenocarcinoma, neoadjuvant treatment, chemotherapy, radiotherapy

Published: February 29, 2012  Show citation